• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion

    (Re)Open for Business: China’s Strong Demand for Natural Products Spells Opportunity for U.S. Brands

    Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders

    KA! Empathogenics: Creating Calm and Connectedness with Inspiration from Nature

    Moms Raise the Bar for Kids Supplements
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    BGG Receives Patent for Saw Palmetto ID Method

    Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification

    Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion

    Verdure Sciences’ Boswellia Ingredient Receives USP Verification

    Sabinsa Commits to Solar Energy Project
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    BGG Receives Patent for Saw Palmetto ID Method

    ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts

    Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion

    Verdure Sciences’ Boswellia Ingredient Receives USP Verification

    Bioiberica’s DAOgest Authorized as Novel Food ingredient in EU
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    BGG Receives Patent for Saw Palmetto ID Method

    The Pet Health Boom: Supplement Growth Set to Build on Rapid Expansion

    ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts

    Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification

    Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    ‘Uniquely Unbound’: Releasing the Potential, and Genius, of Walnuts

    Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion

    Gaming and Esports Health Concerns

    Bioiberica’s DAOgest Authorized as Novel Food ingredient in EU

    Review Finds No Causative Connection Between Dietary Supplements and Eating Disorders
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Xsto Solutions

    Bioenergy Life Science, Inc. (BLS)

    BGG Americas, Inc.

    Gencor

    Applied Food Sciences, Inc.
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Xsto Solutions

    Bioenergy Life Science, Inc. (BLS)

    BGG Americas, Inc.

    Gencor

    Applied Food Sciences, Inc.
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Pfizer and GlaxoSmithKline Enter Global Consumer Healthcare Joint Venture

    Deal will expand GSK’s consumer health portfolio from pure OTC toward the faster-growing vitamins and dietary supplements categories.

    Pfizer and GlaxoSmithKline Enter Global Consumer Healthcare Joint Venture
    12.19.18
    Pfizer Inc. and GlaxoSmithKline plc have entered into an agreement to create a premier global consumer healthcare company. The Boards of Directors of both companies have unanimously approved the transaction under which Pfizer will contribute its consumer healthcare business to GlaxoSmithKline’s existing consumer healthcare business. The 2017 global sales for the combined business were approximately $12.7 billion. 
     
    Matthew Oster, head of consumer health at Euromonitor International, commented on the joint venture, and discussed how the new business would represent the world’s largest consumer health company by far, with around 6% of the global market.
     
    “This deal makes sense on a number of fronts,” noted Mr. Oster. “It brings together a number of global megabrands under one roof, from GSK’s Panadol and Voltaren to Pfizer’s Advil, Centrum and Nexium; together the company will house 25 consumer health brands with more than $100 million in annual retail sales. It also marks a logical end to the rumors about Pfizer’s underperforming consumer health division, which had been reported to be on the block off-and-on for the last couple years. GSK has the capacity to take on a joint venture of this magnitude, as its 2015 JV of Novartis’s consumer health division proved (GSK bought out Novartis’s share of this joint venture earlier this year). GSK has also been able to show steady growth in a consumer health marketplace where many of the leading players, like Pfizer, have seen recent difficulties. It also makes sense in terms of the new company’s geographic portfolio, with Pfizer’s well-built presence in the U.S. complementing GSK’s leading position in Western and Eastern Europe and the Middle East and Africa.”
     
    Additionally, Mr. Oster stressed the joint venture will expand GSK’s consumer health portfolio from pure OTC toward the faster-growing vitamins and dietary supplements categories. He suggested “Pfizer plays more actively [in the supplements category] (with megabrands such as Centrum, Caltrate, Emergen-C and Vitasprint); more than half of Pfizer’s global consumer health sales come in the form of vitamins and dietary supplements, while 95% of GSK’s consumer health sales fall in OTC. This will allow the new merged company take advantage of changing consumer trends around healthy living that are driving interest in vitamins and dietary supplements and will give them a competitive boost in diversifying away from a pure OTC portfolio.”
     
    Commenting on the deal, Ian Read, chairman and current chief executive officer for Pfizer stated: “We are pleased to announce this new joint venture for Pfizer Consumer Healthcare, delivering on our commitment to complete the strategic review for this business in 2018. Pfizer and GSK have an excellent track record of creating successful collaborations, and we look forward to working together again to unlock the potential of our combined consumer healthcare businesses.” 
     
    Under the terms of the transaction, Pfizer will receive a 32% equity stake in the joint venture, entitling Pfizer to its pro rata share of the joint venture’s earnings and dividends, which will be paid on a quarterly basis. Pfizer will have the right to appoint three out of the nine members of the joint venture’s board. The transaction is expected to deliver $650 million in peak cost synergies and to be slightly accretive for Pfizer in each of the first three years after the close of the transaction, which is anticipated during the second half of 2019, subject to receipt of GSK shareholder approval and regulatory approvals, and satisfaction of other customary closing conditions. 
     
    As Pfizer will own less than 50% of the joint venture, Pfizer anticipates deconsolidating Pfizer Consumer Healthcare from its financial statements following the closing of the transaction. In the near- to medium-term, this deconsolidation is not expected to have a material impact on Pfizer’s top-line growth. In addition, given the Consumer Healthcare business records lower margins than Pfizer’s other businesses, the deconsolidation is expected to have a slight positive impact on Pfizer’s operating margins over the next several years. 
     
    Following the integration of the combined business, GSK intends to separate the joint venture as an independent company via a demerger of its equity interest to its shareholders and a listing of the Consumer Healthcare business on the UK equity market. GSK will have the sole right to decide whether and when to initiate a separation and listing for a period of five years from closing of the proposed transaction. GSK may also sell all or part of its stake in the joint venture in a contemporaneous IPO. 
     
    Should a separation and listing occur during the first five years after closing, Pfizer has the option to participate through the distribution of its equity interest in the joint venture to its shareholders or the sale of its equity interest in a contemporaneous IPO. After the fifth anniversary of the closing of the proposed transaction, both GSK and Pfizer will have the right to decide whether and when to initiate a separation and public listing of the joint venture. 
     
    “The combination of these leading businesses with distinct regional and category strengths will be more sustainable and broader in scope than either company individually,” said Albert Bourla, chief operating officer and incoming chief executive officer, Pfizer. “We believe that this joint venture is a great opportunity to ensure the future success of Pfizer Consumer Healthcare while unlocking meaningful after-tax value for Pfizer shareholders.” 
     
    The companies suggested the joint venture will be a category leader in pain relief, respiratory, vitamin and mineral supplements, digestive health, skin health and therapeutic oral health and will be the largest global consumer healthcare business. In addition, the joint venture is expected to be the first or second largest consumer healthcare player in key geographies, including the U.S., Europe, China, India and Australasia. The joint venture will operate globally under the GSK Consumer Healthcare name. 
     
    Emma Walmsley, GSK CEO, will be chair of the new joint venture. Brian McNamara, currently CEO GSK Consumer Healthcare, will be CEO of the new joint venture and Tobias Hestler, currently CFO GSK Consumer Healthcare, will be CFO. 
     
    Until separation, the joint venture will be consolidated in GSK’s financial statements. For the year ended December 31, 2017, the Pfizer Consumer Healthcare business recorded revenues of approximately $3.5 billion and the GSK Consumer Healthcare business recorded revenues of approximately $9.2 billion. 
     
    GSK has agreed to pay a break fee of $900 million if (i) the GSK Board of Directors changes, withdraws or qualifies its recommendation of the transaction to its shareholders for approval; (ii) GSK’s shareholders vote on the proposed transaction and do not approve it; or (iii) GSK’s shareholders do not approve the proposed transaction by September 30, 2019 (subject to extension in certain circumstances). 
     
    Centerview Partners LLC, Guggenheim Securities, LLC and Morgan Stanley & Co. LLC served as Pfizer’s financial advisors, Wachtell, Lipton, Rosen & Katz, and Clifford Chance LLP served as its legal advisors, and Skadden, Arps, Slate, Meagher & Flom LLP served as its tax advisor.
     
    Related Searches
    • Digestive Health
    • China
    • Healthcare
    • Health
    Related Knowledge Center
    • Mergers & Acquisitions
    • Healthcare Trends
    • Dietary Supplements
    • Vitamins
    Suggested For You
    Building on Solid Ground Building on Solid Ground
    How Transformative Tech & Renegade Retail Will Reshape Healthcare How Transformative Tech & Renegade Retail Will Reshape Healthcare
    Sustaining Health ... For People & Planet Sustaining Health ... For People & Planet
    Betting on Health & Wellness Betting on Health & Wellness
    Podcast: Ashwagandha Appeals to Growing Consumer Interest in Adaptogens Podcast: Ashwagandha Appeals to Growing Consumer Interest in Adaptogens
    Cargill & DSM Establish Joint Venture to Bring Steviol  Glycosides to Market Faster Cargill & DSM Establish Joint Venture to Bring Steviol Glycosides to Market Faster
    Natac Solutions Joint Venture to Bring Concentrated Extracts to Market Natac Solutions Joint Venture to Bring Concentrated Extracts to Market
    Cargill & DSM Establish Joint Venture to Bring Steviol Glycosides to Market Faster Cargill & DSM Establish Joint Venture to Bring Steviol Glycosides to Market Faster
    Riding the Sports Nutrition Wave: Energy, Endurance & Recovery Riding the Sports Nutrition Wave: Energy, Endurance & Recovery
    Key Trends in Functional Foods & Beverages for 2019 Key Trends in Functional Foods & Beverages for 2019
    Stratum Nutrition Giving Away Trip to London for Two Stratum Nutrition Giving Away Trip to London for Two
    The Nutritional Quest for Calm The Nutritional Quest for Calm
    Holistic Formulas Promote Weight Wellness Holistic Formulas Promote Weight Wellness
    Feeding the Fast and the Furriest Feeding the Fast and the Furriest

    Related Features

    • Consumer Trends | Healthcare Trends | Natural/Organic | Packaging | World Markets
      Sustaining Health ... For People & Planet

      Sustaining Health ... For People & Planet

      Innovative products and partnerships can help rebuild systems that have degraded the environment and public well-being.
      By Sean Moloughney, Editor 03.01.19

    • Consumer Trends | Healthcare Trends | World Markets
      Building on Solid Ground

      Building on Solid Ground

      The global food system underpins the health of both people and the planet.
      By Sean Moloughney, Editor 03.01.19

    • How Transformative Tech & Renegade Retail Will Reshape Healthcare

      How Transformative Tech & Renegade Retail Will Reshape Healthcare

      Creative thinkers are attempting to remake 17% of the U.S.’s GDP from far outside the healthcare mainstream.
      By Erik Goldman, Holistic Primary Care 03.01.19


    • Dietary Supplements | Functional Foods & Beverages | Healthy Aging
      Betting on Health & Wellness

      Betting on Health & Wellness

      Consumers are taking a proactive approach to health, driving sales in dietary supplements and functional nutrition products.
      By Sean Moloughney, Editor 12.06.18

    • Consumer Trends | Delivery & Dosage Technologies | Functional Foods & Beverages | Herbs & Botanicals | Mood Health & Sleep | Research
      Podcast: Ashwagandha Appeals to Growing Consumer Interest in Adaptogens

      Podcast: Ashwagandha Appeals to Growing Consumer Interest in Adaptogens

      Natreon President discusses how Sensoril ashwagandha supports overall wellness, and why consumers are seeking out adaptogens.
      Lisa Olivo, Associate Editor 12.06.18

    Loading, Please Wait..
    Trending
    • Soviets Took Probiotics To The Next Level
    • Vidya Herbs Invests In US Market With New Facility
    Breaking News
    • BGG Receives Patent for Saw Palmetto ID Method
    • Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
    • Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion
    • Verdure Sciences’ Boswellia Ingredient Receives USP Verification
    • Sabinsa Commits to Solar Energy Project
    View Breaking News >
    CURRENT ISSUE

    May 2023

    • Cellular Aging and Longevity: Ingredients for a New Age of Health
    • Addressing the Plastic-Packaging Problem: Getting to Zero-Waste with Zero Compromise
    • Moms Raise the Bar for Kids Supplements
    • Building on Steps to Improve Children’s Health Around the World
    • FDA Remains Focused on Modernizing DSHEA
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BGG Receives Patent for Saw Palmetto ID Method
    Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
    Inulinase Enzymes May Benefit Gut Symptoms of FODMAP Digestion
    Coatings World

    Latest Breaking News From Coatings World

    Active Minerals International Announces 2023 Price Increase
    BASF Awards $35,000 in Scholarships to Coastal Alabama Community College
    Fischer Homes Selects PPG as Exclusive Paint Provider for New Home Builds
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Acteev Launches Antimicrobial Zinc Technology
    GE HealthCare's Precision DL Deep Learning Image Processing Software Earns FDA Nod
    SANUWAVE Health Appoints Morgan Frank New CEO
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Vinnova Supports Formation of Nordic CCRM Hub
    Astellas to Transfer Manufacturing Plant to Delpharm
    OLON Enters ADC Market
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Two Executives Depart from Unilever Amid CEO Transition
    L’Oréal Paris Welcomes Thuso Mbedu as Brand Ambassador
    Brad Pitt’s Le Domaine Expands Availability Through Bluemercury
    Happi

    Latest Breaking News From Happi

    Global Aroma Chemical-Based Flavor and Fragrance Market Expected to Reach $30 Billion by 2028: ResearchAndMarkets
    Fragrance Creators Names Dr. Dan Selechnik New Director of Regulatory Science
    Global Fish Collagen Peptides Expected to Reach $1.1 Billion by 2031: ResearchAndMarkets
    Ink World

    Latest Breaking News From Ink World

    Nazdar SourceOne Names Matthew Dominguez Insides Sales Representative, US.
    Roland DGA to Hold Open House Event at its Atlanta Imagination Center
    BCF Elects Sharon Harte First Female President in Its History
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Constantia Flexibles and SB Packagings commence joint venture
    Inland donates new VersaStudio printer to local high school
    Contiweb becomes Dscoop sponsor
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Bluepha, TotalEnergies Corbion Form Collaboration
    Investor Prevents Closure of Advansa Manufacturing
    Silonsaari Named CFO Suominen
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Arthrex Launches New Patient-Focused Website for ACL Injuries
    THINK Surgical's TMINI Miniature Robotic Handpiece Gains FDA Nod
    NuVasive Marks 20-Year Milestone of XLIF Procedure
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Japan Display to Acquire JOLED OLED Business
    Epishine, Brilliant Matters Join Forces to Take Light Harvesting to Next Level
    Beontag Launches Global Rebrand to Mark Next Phase of Growth

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login